NewGenIvf (NIVF) Equity Average (2023 - 2025)

NewGenIvf (NIVF) has 3 years of Equity Average data on file, last reported at $12.8 million in Q4 2025.

• In Q4 2025, Equity Average rose 1064.48% year-over-year to $12.8 million; the TTM figure through Dec 2025 stood at $12.8 million (up 1064.48% YoY), while the FY2025 annual figure was $12.8 million, up 1064.48% from the prior year.
• Equity Average rose to $12.8 million in Q4 2025, from $1.1 million in the prior quarter.
• Across five years, Equity Average topped out at $12.8 million in Q4 2025 and bottomed at $1.1 million in Q4 2024.
• A 3-year average of $5.2 million and a median of $1.7 million in 2023 frame the typical range for Equity Average.
• Annual changes were most pronounced in 2024 — Equity Average tumbled 34.35% — and 2025, when it surged 1064.48%.
• Year by year, Equity Average stood at $1.7 million in 2023, then sank by 34.35% to $1.1 million in 2024, then surged by 1064.48% to $12.8 million in 2025.
• The last three Equity Average figures came in at $12.8 million (Q4 2025), $1.1 million (Q4 2024), and $1.7 million (Q4 2023), per Business Quant data.

Peer Comparison